|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.00 EUR | -0.27% |
|
-1.58% | -11.81% |
| 13/05 | Spanish stocks - Factors to watch on May 13 | RE |
| 09/05 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| 9 | ||||||||
| 28 | ||||||||
| 22 | ||||||||
| 28 | ||||||||
| 18 | ||||||||
| 21 | ||||||||
| 22 | ||||||||
| 24 | ||||||||
| 29 | ||||||||
| 27 | ||||||||
| 26 | ||||||||
| 25 | ||||||||
| 19 | ||||||||
| 23 | ||||||||
| 15 | ||||||||
| 16 | ||||||||
| 15 | ||||||||
| 15 | ||||||||
| 17 | ||||||||
| Average | 21 | |||||||
| Weighted average by Cap. | 24 |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
















